September 14, 2019
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
Read More
September 14, 2019
A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas
Read More
September 14, 2019
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)
Read More
September 14, 2019
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Read More
September 14, 2019
Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Read More
September 14, 2019
A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (
Read More
September 14, 2019
Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
Read More
September 14, 2019
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis
Read More
September 14, 2019
Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)
Read More
September 14, 2019
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Read More
September 14, 2019
Long-Term PF-06651600 for the Treatment of Alopecia Areata
Read More
September 14, 2019
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Read More
Load More
X